Abstract: . . .  INR > 4 Highly variable INR ATRIAL FIBRILLATION : CLINICAL ASSESSMENT FOR ANTICOAGULATION This material was prepared by Alabama Quality Assurance Foundation under a contract . . .
. . .  following lists identify those patients at highest risk of thromboembolic complica- tions from AF, and those at highest risk of warfarin-related hemorrhage. RISK FACTORS (RF) FOR THROMBOEMBOLISM . . .
. . .  1987; 147:1561-1564. 3 Hart RG, Benavent O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patietns with atrial fibrillation : a meta-analysis. Ann Intern Med . 1999;131:492-501. . . .
. . .  3 (over) Page 2 GIVING WARFARIN FOR PRIMARY PREVENTION TO 1,000 PATIENTS WITH AF WILL PREVENT 30 STROKES A YEAR AT THE RISK OF 1 MORE INTRACRANIAL . . .
. . .  RG, Benavent O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patietns with atrial fibrillation : a meta-analysis. Ann Intern Med . 1999;131:492-501. *See risk factors . . .
. . .  Benavent O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patietns with atrial fibrillation : a meta-analysis. Ann Intern Med . 1999;131:492-501. *See risk factors (RF) for . . .
--1240,6,103,1697,6198